Evidence map›Paper›PMID 27688303›Full record

ArticleCirculation research2016

Mesenchymal Stem Cells Drive Cardiac Stem Cell Chemotaxis, Proliferation, and Phenotype via CXCR4 and cKit Signaling.

Kenneth Michael Fish

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Circulation research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. VEGF treatment promotes bone marrow-derived CXCR4Experimental and therapeutic medicine · 2017
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Kenneth Michael FishFrom the Cardiovascular Research Center, Mount Sinai School of Medicine, New York, NY. kenneth.fish@mssm.edu.

Funding

TRIP: Targeted Gene Therapy for the Treatment of Heart FailureP50HL112324 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ASCHEIM, DEBORAH DAVIS, HAJJAR, ROGER J. · 2012 to 2014
$6.4M
Targeting Abnormal Calcium Cycling Using Novel Gene Therapy VectorsR01HL119046 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI AKAR, FADI GABRIEL, HAJJAR, ROGER J. · 2014 to 2017
$2.9M
NHLBI NIH HHS P50 HL112324NHLBI NIH HHS R01 HL119046
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ChemotaxisMesenchymal Stem CellsCell ProliferationChemokine CXCL12Mesenchymal Stem Cell TransplantationMyocardial InfarctionPhenotypeProto-Oncogene Proteins c-kitReceptors, CXCR4Chemokine CXCL12Proto-Oncogene Proteins c-kitReceptors, CXCR4apoptosischemotaxisdilated cardiomyopathyEditorialsendotheliummyocardial infarction

Identifiers

PMID27688303
PMCPMC5076554

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.